Literature DB >> 16755183

Definitive radiotherapy for tonsillar squamous cell carcinoma.

William M Mendenhall1, Christopher G Morris, Robert J Amdur, Russell W Hinerman, Robert S Malyapa, John W Werning, Christopher D Lansford, Douglas B Villaret.   

Abstract

PURPOSE: The purpose of this study is to update our experience with definitive radiotherapy (RT) for carcinoma of the tonsillar area. PATIENTS AND METHODS: There were 503 patients treated between October 1964 and May 2003 (potential follow-up for at least 2 years). Of these, 198 patients underwent a planned neck dissection and 57 patients received induction (18 patients) or concomitant (39 patients) chemotherapy.
RESULTS: The 5-year local control rates were as follows: T1, 88%; T2, 84%; T3, 78%; and T4, 61%. Multivariate analysis revealed that local control was significantly influenced by T stage, primary site, and fractionation. Local control after RT for early stage cancers was higher for tonsillar fossa/posterior pillar tumors than for those arising from the anterior tonsillar pillar. The 5-year cause-specific survival rates were as follows: I, 100%; II, 86%; III, 84%; IVA, 73%; and IVB, 46%. Multivariate analysis revealed that cause-specific survival was significantly influenced by T stage, overall stage, neck dissection, race, and gender. The incidence of severe late complications was 9%.
CONCLUSION: Based on our data and a review of the literature, definitive RT provides cure rates that are as good as those after surgery, and is associated with a lower rate of severe complications. Patients with lateralized tumors may be safely treated with ipsilateral field arrangements. Our limited experience with intensity modulated radiotherapy suggests that it is as efficacious as conventional RT.

Entities:  

Mesh:

Year:  2006        PMID: 16755183     DOI: 10.1097/01.coc.0000209510.19360.f9

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  19 in total

Review 1.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil.

Authors:  William R Kennedy; Michael P Herman; Rohan L Deraniyagala; Robert J Amdur; John W Werning; Peter Dziegielewski; Jessica Kirwan; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-08       Impact factor: 2.503

3.  When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma?

Authors:  William M Mendenhall; Primož Strojan; Avraham Eisbruch; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

Review 4.  Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Authors:  Douglas E Peterson; Wolfgang Doerr; Allan Hovan; Andres Pinto; Debbie Saunders; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-06       Impact factor: 3.603

5.  Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer.

Authors:  J W L van Loon; L E Smeele; F J M Hilgers; M W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

6.  Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancer.

Authors:  Paul M Harari; Shiyu Song; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-06       Impact factor: 7.038

7.  Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria.

Authors:  J D Hamilton; S Ahmed; V C Sandulache; S P Daram; T J Ow; H D Skinner; A Rao; L E Ginsberg; A J Kumar; J N Myers
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-07       Impact factor: 3.825

8.  Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.

Authors:  William R Kennedy; Michael P Herman; Rohan L Deraniyagala; Robert J Amdur; John W Werning; Peter T Dziegielewski; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-30       Impact factor: 2.503

9.  Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.

Authors:  Kathryn M Greven; Douglas R White; J Dale Browne; Daniel W Williams; W Fred McGuirt; Ralph B D'Agostino
Journal:  Am J Clin Oncol       Date:  2008-06       Impact factor: 2.339

Review 10.  Head and neck cancer.

Authors:  Athanassios Argiris; Michalis V Karamouzis; David Raben; Robert L Ferris
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.